Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
life sciences
national blog main
boston blog main
clinical trials
fda
alprazolam
amgen
bempedoic acid
biopharma
boston
boston top stories
cgrp inhibitors
cholesterol
chronic migraine
colucid pharmaceuticals
corticosteroids
deals
detroit
detroit blog main
detroit top stories
drug enforcement administration
duchenne
eli lilly
esperion therapeutics
europe blog main
europe top stories
ezetimibe
fluoroquinolones
indiana
indiana blog main
indiana top stories
lasmiditan
licensing
m&a
migraine research foundation
muscular dystrophy
national top stories
raleigh-durham blog main
raleigh-durham top stories
What
fda
3
×
second
3
×
approval
drug
therapeutics
won
acute
addresses
approved
betting
billion
biopharma
causes
cholesterol
combo
condition
deal
decades
duchenne
eli
esperion
esperion’s
friday
gene
giant
giving
historic
lasmiditan
levels
lilly
lilly’s
lowering
medication
medicine
medicines
migraine
new
nod
oks
pairs
Language
unset
Current search:
fda
×
biotech
×
second
×
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
